Endogenous GLP-1 mediates postprandial reductions in activation in central reward and satiety areas in patients with type 2 diabetes
Compared to the number of psychiatric AEs reported in 2021 ( n = 935) and 2022 ( n = 893), the psychiatric AEs of GLP-1 RAs reported in Q1 alone in 2023 reached a whopping 411 cases, demonstrating the growing clinical use of GLP-1 RAs
GLP-1 medications have been treating type 2 diabetes since 2005 - but that certainly hasnt stopped the internet rumour mill
Trends in Cardiovascular Medicine, 33 (3), 159-166
These typically improve over 48 weeks but may necessitate slower titration or discontinuation Injection site reactions : Erythema, pruritus, or discomfort at injection sites Fatigue and dizziness : Reported by some patients, particularly initially Gallbladder disease : Rapid weight loss increases cholelithiasis risk
BIE3 ALCACHOFA 80 CAPSULAS Bie3 Alcachofa es tu aliado ideal para mejorar la digestin de las grasas y depurar el organismo